the incidence of dncb positive reactions was 80 per cent in patients with epidermold carcinoma versus 57 per cent in patients with adenocarcinoma , 64 per cent in patients with oat cell cancer , and 80 per cent in patients with terminal bronchiolar carcinoma .
C0001418
adenocarcinoma
C0007120
terminal bronchiolar carcinoma